Literature DB >> 20200612

Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography.

E-S Tan1, P A Van der Vleuten, G A J Jessurun, R A Tio, F Zijlstra, I C Van Gelder.   

Abstract

Background. Little is known about the diagnostic accuracy of global LV function assessment by electromechanical endocardial mapping (EEM). The aim of the present study was to determine the relationship between global left ventricular (LV) function measured by EEM and biplane left ventricular contrast angiography (LVA) after ST-elevation myocardial infarction (STEMI).Methods. Thirty-seven patients underwent LVA and EEM during routine coronary angiography four months after primary percutaneous intervention for STEMI. Global LV function parameters were available from both techniques in all patients. LVA was regarded as reference standard.Results. All procedures were carried out without adverse events. Average age was 55+/-10 years and 84% were male. EEM showed an overestimation of end-diastolic volume (EDV) and end-systolic volume (ESV) of 6.5 ml and 25.5 ml, respectively. Correlation (r) was 0.84 (p<0.001) for EDV and 0.74 (p<0.001) for ESV. Average left ventricular ejection fraction (LVEF) measured by EEM was 17.2% point (+/-11.3% point) lower compared with LVA (r=0.69, p<0.001).Conclusion. Although global functional parameters by EEM correlated well with LVA, the relatively large differences in terms of absolute values for ventricular volumes and LVEF render the two techniques non-interchangeable for global LV-function-data. (Neth Heart J 2010;18:72-77.).

Entities:  

Keywords:  Body Surface Potential Mapping; Contrast Media; Coronary Angiography; Ventricular Function, Left

Year:  2010        PMID: 20200612      PMCID: PMC2828566          DOI: 10.1007/BF03091741

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  17 in total

1.  Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography.

Authors:  E-S Tan; P A Van der Vleuten; G A J Jessurun; R A Tio; F Zijlstra; I C Van Gelder
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

5.  Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

Authors:  Alexander Hirsch; Robin Nijveldt; Pieter A van der Vleuten; Bart J Biemond; Pieter A Doevendans; Albert C van Rossum; Jan G Tijssen; Felix Zijlstra; Jan J Piek
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia.

Authors:  P R Vale; D W Losordo; C E Milliken; M C McDonald; L M Gravelin; C M Curry; D D Esakof; M Maysky; J F Symes; J M Isner
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

8.  Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique.

Authors:  G Van Langenhove; J N Hamburger; P C Smits; M Albertal; E Onderwater; I P Kay; P W Serruys
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

9.  Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.

Authors:  R A Tio; T Tkebuchava; T H Scheuermann; C Lebherz; M Magner; M Kearny; D D Esakof; J M Isner; J F Symes
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

10.  The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention.

Authors:  Pieter A van der Vleuten; Saman Rasoul; Willem Huurnink; Iwan Cc van der Horst; Riemer Hja Slart; Stoffer Reiffers; Rudi A Dierckx; René A Tio; Jan Paul Ottervanger; Menko-Jan De Boer; Felix Zijlstra
Journal:  BMC Cardiovasc Disord       Date:  2008-02-23       Impact factor: 2.298

View more
  2 in total

1.  Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography.

Authors:  E-S Tan; P A Van der Vleuten; G A J Jessurun; R A Tio; F Zijlstra; I C Van Gelder
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

Review 2.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.